Manufacturer of Controlled Substances; Applications

Federal Register: September 8, 2009 (Volume 74, Number 172)

Notices

Page 46232

From the Federal Register Online via GPO Access [wais.access.gpo.gov]

DOCID:fr08se09-110

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal

Regulations (CFR), this is notice that on March 18, 2009, Research

Triangle Institute, Kenneth H. Davis Jr., Hermann Building, East

Institute Drive, P.O. Box 12194, Research Triangle, North Carolina 27709, made application by renewal to the Drug Enforcement

Administration (DEA) as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II:

Drug

Schedule

Marihuana (7360)........................... I

Tetrahydrocannabinols (7370)............... I

Cocaine (9041)............................. II

The Institute will manufacture small quantities of cocaine and marihuana derivatives for use by their customers in analytical kits, reagents, and reference standards as directed by the National Institute on Drug Abuse.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of

Diversion Control, Federal Register Representative (ODL), 8701

Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than November 9, 2009.

Dated: August 21, 2009.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug

Enforcement Administration.

FR Doc. E9-21526 Filed 9-4-09; 8:45 am

BILLING CODE 4410-09-P

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT